Hiywot Takkele, MS
Vice President, Clinical Operations
Hiywot joined BridgeBio Pharma in 2019, leading a Phase 3 program in urothelial carcinoma and is now Vice President of Clinical Operations at BBOT where she leads the department with active early-phase clinical trials. Prior to joining BridgeBio, Hiywot spent more than 15 years in clinical research, managing rare diseases and oncology trials at BioMarin, Dynavax, and Exelixis.
Hiywot completed her MS in Health Sciences, Biotechnology emphasis from George Washington University, and her BS in Nutrition Science at UC Davis.